Funder: Breakthrough T1D

Due Dates: October 29, 2025 (Letter of Intent) | January 13, 2026 (Full proposal)

Funding Amounts: Up to $3,000,000 total for up to 3 years; budget must match scope; both smaller and larger budgets considered with justification.

Summary: Supports clinical trials to advance therapies for cardiovascular disease in individuals with type 1 diabetes.

Key Information: LOI approval is required before submitting a full proposal.